首页> 外文期刊>Psychiatry and Clinical Psychopharmacology >Diurnal enuresis developing in association with risperidone and aripiprazole use in a child with autism spectrum disorder: a case report
【24h】

Diurnal enuresis developing in association with risperidone and aripiprazole use in a child with autism spectrum disorder: a case report

机译:利培酮和阿立哌唑与儿童自闭症谱系障碍相关的昼夜遗尿症:一例报告

获取原文
       

摘要

Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder. Risperidone and Aripiprazole appear to be effective in associated behavioural problems with ASDs, including irritability, aggressiveness, hyperactivity, self-injurious behaviour, and stereotypies. In our case, new-onset diurnal enuresis was observed as a side effect after risperidone use. New-onset diurnal enuresis improved when risperidone was stopped, but recommenced when aripiprazole was added to treatment. However, all symptoms of enuresis resolved when the aripiprazole dosage was reduced. In contrast to some reports in which aripiprazole was used in the treatment of enuresis, our case is different in that it led to diurnal enuresis.
机译:自闭症谱系障碍(ASD)是一种复杂的异质性神经发育障碍。利培酮和阿立哌唑在与自闭症相关的行为问题中似乎有效,包括烦躁,攻击性,活动过度,自残行为和刻板印象。在我们的病例中,使用利培酮后观察到新发的昼夜遗尿症为副作用。停止使用利培酮后新发的昼夜遗尿症改善,但当加入阿立哌唑治疗后重新开始。但是,减少阿立哌唑的剂量后,所有的遗尿症状都会缓解。与一些报告使用阿立哌唑治疗遗尿症相反,我们的病例不同之处在于它导致了每日遗尿症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号